604 related articles for article (PubMed ID: 7518309)
1. Metabolism of methylarginines by human vasculature; implications for the regulation of nitric oxide synthesis.
MacAllister RJ; Fickling SA; Whitley GS; Vallance P
Br J Pharmacol; 1994 May; 112(1):43-8. PubMed ID: 7518309
[TBL] [Abstract][Full Text] [Related]
2. Induction of NG-monomethyl-L-arginine uptake: a mechanism for differential inhibition of NO synthases?
Bogle RG; MacAllister RJ; Whitley GS; Vallance P
Am J Physiol; 1995 Sep; 269(3 Pt 1):C750-6. PubMed ID: 7573406
[TBL] [Abstract][Full Text] [Related]
3. Platelet adhesion to human vascular endothelium is modulated by constitutive and cytokine induced nitric oxide.
Radomski MW; Vallance P; Whitley G; Foxwell N; Moncada S
Cardiovasc Res; 1993 Jul; 27(7):1380-2. PubMed ID: 7504587
[TBL] [Abstract][Full Text] [Related]
4. Effects of guanidino and uremic compounds on nitric oxide pathways.
MacAllister RJ; Whitley GS; Vallance P
Kidney Int; 1994 Mar; 45(3):737-42. PubMed ID: 7515129
[TBL] [Abstract][Full Text] [Related]
5. Reduction by NG-nitro-L-arginine of H2O2-induced endothelial cell injury.
Shimizu S; Nomoto M; Yamamoto T; Momose K
Br J Pharmacol; 1994 Oct; 113(2):564-8. PubMed ID: 7530574
[TBL] [Abstract][Full Text] [Related]
6. Selective inhibition of basal but not agonist-stimulated activity of nitric oxide in rat aorta by NG-monomethyl-L-arginine.
Frew JD; Paisley K; Martin W
Br J Pharmacol; 1993 Nov; 110(3):1003-8. PubMed ID: 7507774
[TBL] [Abstract][Full Text] [Related]
7. Regulation of nitric oxide synthesis by dimethylarginine dimethylaminohydrolase.
MacAllister RJ; Parry H; Kimoto M; Ogawa T; Russell RJ; Hodson H; Whitley GS; Vallance P
Br J Pharmacol; 1996 Dec; 119(8):1533-40. PubMed ID: 8982498
[TBL] [Abstract][Full Text] [Related]
8. Activation of nitric oxide synthase by beta 2-adrenoceptors in human umbilical vein endothelium in vitro.
Ferro A; Queen LR; Priest RM; Xu B; Ritter JM; Poston L; Ward JP
Br J Pharmacol; 1999 Apr; 126(8):1872-80. PubMed ID: 10372832
[TBL] [Abstract][Full Text] [Related]
9. Localization and role of nitric oxide synthase and endogenous nitric oxide synthase inhibitors in the rabbit lower urinary tract.
Masuda H; Tsujii T; Okuno T; Kihara K; Goto M; Azuma H
J Urol; 2002 May; 167(5):2235-40. PubMed ID: 11956485
[TBL] [Abstract][Full Text] [Related]
10. Modification of striatal arginine and citrulline metabolism by nitric oxide synthase inhibitors.
Ohta K; Shimazu K; Komatsumoto S; Araki N; Shibata M; Fukuuchi Y
Neuroreport; 1994 Mar; 5(7):766-8. PubMed ID: 7517194
[TBL] [Abstract][Full Text] [Related]
11. [Biological and pathophysiological roles of endogenous methylarginines as inhibitors of nitric oxide synthase].
Masuda H; Azuma H
Nihon Yakurigaku Zasshi; 2002 Jan; 119(1):29-35. PubMed ID: 11862754
[TBL] [Abstract][Full Text] [Related]
12. L-NG-nitro arginine (L-NOARG), a novel, L-arginine-reversible inhibitor of endothelium-dependent vasodilatation in vitro.
Moore PK; al-Swayeh OA; Chong NW; Evans RA; Gibson A
Br J Pharmacol; 1990 Feb; 99(2):408-12. PubMed ID: 2328404
[TBL] [Abstract][Full Text] [Related]
13. Nitric oxide synthase inhibitors and hypertension in children and adolescents.
Goonasekera CD; Rees DD; Woolard P; Frend A; Shah V; Dillon MJ
J Hypertens; 1997 Aug; 15(8):901-9. PubMed ID: 9280214
[TBL] [Abstract][Full Text] [Related]
14. Regulation of nitric oxide-like activity by prostanoids in smooth muscle of the canine saphenous vein.
Illiano S; Marsault R; Descombes JJ; Verbeuren T; Vanhoutte PM
Br J Pharmacol; 1996 Jan; 117(2):360-4. PubMed ID: 8789391
[TBL] [Abstract][Full Text] [Related]
15. Production of angiogenic activity by human monocytes requires an L-arginine/nitric oxide-synthase-dependent effector mechanism.
Leibovich SJ; Polverini PJ; Fong TW; Harlow LA; Koch AE
Proc Natl Acad Sci U S A; 1994 May; 91(10):4190-4. PubMed ID: 7514298
[TBL] [Abstract][Full Text] [Related]
16. Inhibition by methylene blue of the L-arginine metabolism to L-citrulline coupled with nitric oxide synthesis in cultured endothelial cells.
Shimizu S; Yamamoto T; Momose K
Res Commun Chem Pathol Pharmacol; 1993 Oct; 82(1):35-48. PubMed ID: 7505944
[TBL] [Abstract][Full Text] [Related]
17. Interactions of nitric oxide synthase inhibitors and dexamethasone with alpha-adrenoceptor-mediated responses in rat aorta.
Adeagbo AS; Triggle CR
Br J Pharmacol; 1993 Jun; 109(2):495-501. PubMed ID: 7689395
[TBL] [Abstract][Full Text] [Related]
18. Time-dependent enhancement or inhibition of endotoxin-induced vascular injury in rat intestine by nitric oxide synthase inhibitors.
Laszlo F; Whittle BJ; Moncada S
Br J Pharmacol; 1994 Apr; 111(4):1309-15. PubMed ID: 7518298
[TBL] [Abstract][Full Text] [Related]
19. Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo.
Rees DD; Palmer RM; Schulz R; Hodson HF; Moncada S
Br J Pharmacol; 1990 Nov; 101(3):746-52. PubMed ID: 1706208
[TBL] [Abstract][Full Text] [Related]
20. Characterization of an inhibitor of nitric oxide synthase in human-hand veins.
Bedarida GV; Kim D; Blaschke TF; Hoffman BB
Horm Metab Res; 1994 Feb; 26(2):109-12. PubMed ID: 7515369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
